The US Food and Drug Administration (FDA) has approved diabetes drug Liraglutide (Saxenda, Novo Nordisk) for the treatment of obesity.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/us-fda-clears-diabetes-drug-treatment-obesity
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/asian-age-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-states-america-us
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/obesity
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diabetes
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-states-food-and-drug-administration-et-al